News

Herbal antioxidants are becoming increasingly important

123sonography Acquires the SonoWorld Website from Inteleos

AOP Orphan Pharmaceuticals AG and Chord Therapeutics Announce a Partnership to Develop CRD1 (Cladribine) for Treatment of Orphan Autoimmune Diseases

Valneva Announces its Intention to Delist from the Vienna Stock

Valneva Announces its Intention to Delist from the Vienna Stock

HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead

Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate

Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate

Curetis’ Subsidiary Ares Genetics Teams Up with Leading

Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate

HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus

AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®

AddLife acquires Austrian Biomedica – international expansion on 13 new markets

Small but versatile – Key players in the marine nitrogen cycle can utilize cyanate and urea

Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement

AOP Orphan announces three-year results on Ropeginterferon alfa-2b in Polycythemia Vera at ASH

AWARD FOR PHAGE THERAPY: PHAGOMED WINS AUSTRIAN ENTREPRENEURSHIP AWARD PHÖNIX

EANS-Adhoc: Marinomed Biotech AG suspends offer period of the current IPO

HOOKIPA and DarwinHealth Enter into a Research Collaboration and License Agreement

VIENNESE BIOTECH COMPANY MARINOMED DEMONSTRATES THE BENEFITS OF ITS PATENTED MARINOSOLV® TECHNOLOGY